NSE
GlaxoSmithKline Pharmaceuticals LimitedGLAXO
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) is an NSE-listed company. This page brings together its recent bulk & block deals, AI-scored exchange filings and corporate actions.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Rs 57 Per Share
ex 2026-05-29
Filings that matter
- 2Annual reportNeutral
The company announced its annual report for the fiscal year ended March 31, 2026. - Focus on biopharmaceutical innovation with a strategic expansion into specialty areas like adult immunisation and cancer care. Impact: 2/10 · Neutral
Source PDF → - 2GeneralNeutral
The company is holding its 101st Annual General Meeting (AGM) through video conferencing. - Dividends of Rs. 57 per share are declared for the financial year ended March 31, 2026. Impact: 2/10 · Neutral
Source PDF →
Bulk & block deals
No recent bulk/block deals for GLAXO.
Results & transcripts
Financial results
Calls & transcripts
None yet.